Abstract 4852: Chlorogenic Acid Ameliorates Heart Failure with Comorbid Depression via GPX4/ACSL4 Axis-Mediated Inhibition of Lipid Peroxidation and Ferroptosis
Chlorogensäure lindert Herzinsuffizienz mit komorbider Depression über die GPX4/ACSL4-Achse durch Hemmung von Lipidperoxidation und Ferroptose
Circulation · 02.11.2026 · 154 (Suppl_1)
DOI: 10.1161/circ.154.suppl_1.4852 ↗Auf einen Blick
In einem Mausmodell verbesserte Chlorogensäure die Herzfunktion und depressive-ähnliche Verhaltensweisen. Begleitend nahmen kardiale und hippocampale Schäden ab.
Fragestellung
Wie wirkt Chlorogensäure bei Herzinsuffizienz mit komorbider Depression im Mausmodell?
Methode
C57BL/6-Mäuse mit LAD-Ligation und chronischem Restraint-Stress; Vergleich von Kontrolle, Modell sowie niedriger und hoher CGA-Dosis; zudem Ferrostatin-1 und Erastin zur pharmakologischen Validierung.
Ergebnisse
Gegenüber der Modellgruppe verbesserte CGA das linksventrikuläre Remodeling, die Lokomotion und die immobility time im Tail-Suspension- und Forced-Swim-Test. MDA sank, GPX4 stieg, ACSL4 sank, BDNF stieg.
Schlussfolgerung der Autor:innen
CGA verbesserte kardiale Dysfunktion, depressive-ähnliche Verhaltensweisen und kardiale/hippocampale Pathologie bei HF mit Depression durch Modulation der GPX4/ACSL4-Achse und Hemmung von Lipidperoxidation und Ferroptose.
Kernaussagen
- Mausmodell mit Herzinsuffizienz und depressionsähnlichem Verhalten
- CGA verbesserte Herzfunktion und Verhaltensparameter
- GPX4 rauf, ACSL4 runter, MDA reduziert
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Kai Huang und 3 weiteren Autor:innen.
Themen: Herzinsuffizienz, Depression
Abstract (Originalsprache)
BACKGROUND: Comorbid depression is highly prevalent in heart failure (HF) and associates with poor quality of life, cardiac deterioration, and rehospitalization. Recent studies have indicated that, in addition to oxidative stress, inflammation, and neuroendocrine imbalance, ferroptosis (a form of programmed cell death driven by iron-dependent lipid peroxidation) may represent a crucial pathological link between cardiac injury and mood disorders. Chlorogenic acid (CGA) has antioxidant, anti-inflammatory and cardioprotective effects, but its intervention effect and mechanism on HF comorbid depression remain unclear. METHODS: C57BL/6 mice were subjected to left anterior descending coronary artery ligation combined with chronic restraint stress to establish a model of HF with comorbid depression, and were randomly divided into control, model, and low- and high-dose CGA intervention groups. Cardiac function was assessed by echocardiography; depressive-like behaviors were evaluated using the open field test, tail suspension test, and forced swim test; myocardial and hippocampal pathological changes were observed by H&E, Masson’s trichrome, and Nissl staining. In addition, proteomic profiling, bioinformatics analysis, Western blot, immunofluorescence, MDA detection and transmission electron microscopy were employed to evaluate lipid peroxidation and ferroptosis-related alterations. Furthermore, ferrostatin-1 and erastin were used for in vivo pharmacological validation. RESULTS: Compared with the model group, CGA-treated mice exhibited significantly improved left ventricular remodeling, increased locomotor activity in the open field test, and reduced immobility time in the tail suspension and forced swim tests, indicating attenuation of depressive-like behaviors. Histologically, CGA alleviated myocardial structural disorganization, collagen deposition, hippocampal neuronal injury, and Nissl body loss. Lipid peroxidation-related pathways were significantly enriched in the heart and hippocampus of model mice. Mechanistically, CGA treatment reduced MDA levels, upregulated GPX4, downregulated ACSL4, restored BDNF expression, and attenuated ferroptosis-associated mitochondrial damage. Moreover, the ferroptosis inhibitor ferrostatin-1 partially mimicked the protective effects of CGA, whereas the ferroptosis inducer erastin attenuated or even reversed these effects. CONCLUSIONS: CGA ameliorates cardiac dysfunction, depressive-like behaviors, and cardiac/hippocampal pathology in HF with depression by modulating the GPX4/ACSL4 axis and inhibiting lipid peroxidation and ferroptosis. This study suggests that CGA has the potential to become a therapeutic drug for HF with depression, and provides experimental evidence for the ferroptosis-mediated interaction between the heart and brain.
Zitieren
APA
Huang, K., Zhang, D., Wang, R., & yang, L. (2026). Abstract 4852: Chlorogenic Acid Ameliorates Heart Failure with Comorbid Depression via GPX4/ACSL4 Axis-Mediated Inhibition of Lipid Peroxidation and Ferroptosis. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.4852
Vancouver
Huang K, Zhang D, Wang R, yang L. Abstract 4852: Chlorogenic Acid Ameliorates Heart Failure with Comorbid Depression via GPX4/ACSL4 Axis-Mediated Inhibition of Lipid Peroxidation and Ferroptosis. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.4852
BibTeX
@article{Huang2026,
author = {Huang, Kai and Zhang, Duosu and Wang, Ruting and yang, ling},
title = {Abstract 4852: Chlorogenic Acid Ameliorates Heart Failure with Comorbid Depression via GPX4/ACSL4 Axis-Mediated Inhibition of Lipid Peroxidation and Ferroptosis},
journal = {Circulation},
year = {2026},
volume = {154},
number = {Suppl_1},
doi = {10.1161/circ.154.suppl_1.4852}
}
EUVIMED